Oncode Institute
Overview
Oncode Institute is a Dutch cancer research and innovation organization that provides pre-seed and seed investments to oncology-focused spin-off companies through its Oncode Oncology Bridge Fund.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Laigo Bio | Mar 2026 | Seed | Co-investor |
| Flindr Therapeutics | Apr 2024 | Series A | Co-investor |
| Single Cell Discoveries | Sep 2018 | Seed | Lead |
| Flindr Therapeutics | - | Seed | Co-investor |
Key People
René Kuijten
Initiator & Founder, Vice-chairman Supervisory Board
Carolien Hovenier
Patient Partner
Gerrit Oostenveld
Patient Partner
Anne Rios
Principal Investigator
Jacco van Rheenen
Principal Investigator
Jop Kind
Principal Investigator
Lodewyk Wessels
Oncode Principal Investigator
Louis Vermeulen
Principal Investigator
Madelon Maurice
Principal Investigator
Mario van der Stelt
Principal Investigator
Miao-Ping Chien
Principal Investigator
Rebekka K. Schneider
Principal Investigator
Ruben van Boxtel
Principal Investigator At The Princess Máxima Center And Oncode Institute
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
